Heart Rhythm

Article	Citations
Recognizing COVID-19–related myocarditis: The possible pathophysiology and proposed guideline for diagnosis and management	528
COVID-19 and cardiac arrhythmias	306
COVID-19 cardiac injury: Implications for long-term surveillance and outcomes in survivors	205
QT interval prolongation and torsade de pointes in patients with COVID-19 treated with hydroxychloroquine/azithromycin	193
2020 APHRS/HRS expert consensus statement on the investigation of decedents with sudden unexplained death and patients with sudden cardiac arrest, and of their families	148
SARS-CoV-2, COVID-19, and inherited arrhythmia syndromes	147
Guidance for cardiac electrophysiology during the COVID-19 pandemic from the Heart Rhythm Society COVID-19 Task Force; Electrophysiology Section of the American College of Cardiology; and the Electroc	145
QT prolongation, torsades de pointes, and sudden death with short courses of chloroquine or hydroxychloroquine as used in COVID-19: A systematic review	127
Left bundle branch–optimized cardiac resynchronization therapy (LOT-CRT): Results from an international LBBAP collaborative study group	113
Clinical outcomes of left bundle branch area pacing compared to right ventricular pacing: Results from the Geisinger-Rush Conduction System Pacing Registry	108
Physiology-based electrocardiographic criteria for left bundle branch capture	107
Association of SGLT2 inhibitors with arrhythmias and sudden cardiac death in patients with type 2 diabetes or heart failure: A meta-analysis of 34 randomized controlled trials	102
The possible association between COVID-19 and postural tachycardia syndrome	102
Stereotactic arrhythmia radioablation for refractory scar-related ventricular tachycardia	89
Cryoballoon ablation of pulmonary veins for persistent atrial fibrillation: Results from the multicenter STOP Persistent AF trial	89
Cardiac radioablation—A systematic review	88
2023 HRS/APHRS/LAHRS guideline on cardiac physiologic pacing for the avoidance and mitigation of heart failure	85
Leadless pacemakers reduce risk of device-related infection: Review of the potential mechanisms	76
Clinical outcomes of conduction system pacing compared to biventricular pacing in patients requiring cardiac resynchronization therapy	76
Intermediate-term performance and safety of His-bundle pacing leads: A single-center experience	75
European Heart Rhythm Association (EHRA)/Heart Rhythm Society (HRS)/Asia Pacific Heart Rhythm Society (APHRS)/Latin American Heart Rhythm Society (LAHRS) Expert Consensus Statement on the State of Gen	74
Long-term impact of catheter ablation on arrhythmia burden in low-risk patients with paroxysmal atrial fibrillation: The CLOSE to CURE study	74
Atrial fibrillation is an independent predictor for in-hospital mortality in patients admitted with SARS-CoV-2 infection	73
Left bundle branch pacing compared to left ventricular septal myocardial pacing increases interventricular dyssynchrony but accelerates left ventricular lateral wall depolarization	72
Wearables in cardiology: Here to stay	68

Genetic susceptibility for COVID-19–associated sudden cardiac death in African Americans	65
Marshall bundle elimination, Pulmonary vein isolation, and Line completion for ANatomical ablation of persistent atrial fibrillation (Marshall-PLAN): Prospective, single-center study	64
Off-label dosing of non–vitamin K antagonist oral anticoagulants and clinical outcomes in Asian patients with atrial fibrillation	62
A new smart wristband equipped with an artificial intelligence algorithm to detect atrial fibrillation	60
Epicardial course of the septopulmonary bundle: Anatomical considerations and clinical implications for roof line completion	60
Dysautonomia following COVID-19 is not associated with subjective limitations or symptoms but is associated with objective functional limitations	57
Postural orthostatic tachycardia syndrome as a sequela of COVID-19	56
Fixation beats: A novel marker for reaching the left bundle branch area during deep septal lead implantation	54
2021 PACES Expert Consensus Statement on the Indications and Management of Cardiovascular Implantable Electronic Devices in Pediatric Patients	53
Generalizability of the CASTLE-AF trial: Catheter ablation for patients with atrial fibrillation and heart failure in routine practice	53
Real-world experience of leadless left ventricular endocardial cardiac resynchronization therapy: A multicenter international registry of the WiSE-CRT pacing system	53
Oral anticoagulant and reduced risk of dementia in patients with atrial fibrillation: A population-based cohort study	52
Deep learning for comprehensive ECG annotation	50
Effects of hydroxychloroquine treatment on QT interval	49
Acute and long-term results of bipolar radiofrequency catheter ablation of refractory ventricular arrhythmias of deep intramural origin	48
Electrophysiological characteristics of septal perforation during left bundle branch pacing	47
Rescue left bundle branch area pacing in coronary venous lead failure or nonresponse to biventricular pacing: Results from International LBBAP Collaborative Study Group	47
Catheter ablation of atrial fibrillation using ablation index–guided high power (50 W) for pulmonary vein isolation with or without esophageal temperature probe (the AI-HP ESO II)	47
Evolution of risk stratification and sudden death prevention in hypertrophic cardiomyopathy: Twenty years with the implantable cardioverter-defibrillator	45
Esophageal temperature dynamics during high-power short-duration posterior wall ablation	44
A circadian clock in the sinus node mediates day-night rhythms in Hcn4 and heart rate	44
His-bundle and left bundle pacing with optimized atrioventricular delay achieve superior electrical synchrony over endocardial and epicardial pacing in left bundle branch block patients	43
The World-wide Randomized Antibiotic Envelope Infection Prevention (WRAP-IT) trial: Long-term follow-up	43
Cardioneuroablation for vasovagal syncope: A systematic review and meta-analysis	42
High-throughput discovery of trafficking-deficient variants in the cardiac potassium channel KV11.1	41
Ablation strategies for intramural ventricular arrhythmias	39
Predictors of atrial mechanical sensing and atrioventricular synchrony with a leadless ventricular pacemaker: Results from the MARVEL 2 Study	38
Rationale, considerations, and goals for atrial fibrillation centers of excellence: A Heart Rhythm Society perspective	37
Major adverse clinical events associated with implantation of a leadless intracardiac pacemaker	37
Subcutaneous versus transvenous implantable defibrillator: An updated meta-analysis	37
His-bundle pacing vs biventricular pacing following atrioventricular nodal ablation in patients with atrial fibrillation and reduced ejection fraction: A multicenter, randomized, crossover study—The A	36
Validation of an algorithm for continuous monitoring of atrial fibrillation using a consumer smartwatch	35
Bipolar radiofrequency ablation for ventricular tachycardias originating from the interventricular septum: Safety and efficacy in a pilot cohort study	35
Chloroquine-induced torsades de pointes in a patient with coronavirus disease 2019	34
Ectopy-triggering ganglionated plexuses ablation to prevent atrial fibrillation: GANGLIA-AF study	34
Mechanisms of atrial fibrillation in aged rats with heart failure with preserved ejection fraction	34
High-power, short-duration atrial fibrillation ablations using contact force sensing catheters: Outcomes and predictors of success including posterior wall isolation	34
Filamin-C variant-associated cardiomyopathy: A pooled analysis of individual patient data to evaluate the clinical profile and risk of sudden cardiac death	33
Both selective and nonselective His bundle, but not myocardial, pacing preserve ventricular electrical synchrony assessed by ultra-high-frequency ECG	33
Leadless left ventricular stimulation with WiSE-CRT System – Initial experience and results from phase I of SOLVE-CRT Study (nonrandomized, roll-in phase)	33
Cardiac potassium inward rectifier Kir2: Review of structure, regulation, pharmacology, and arrhythmogenesis	33
Combined local impedance and contact force for radiofrequency ablation assessment	33
Novel risk calculator performance in athletes with arrhythmogenic right ventricular cardiomyopathy	32
High-resolution, live, directional mapping	32
Leadless atrioventricular synchronous pacing in an outpatient setting: Early lessons learned on factors affecting atrioventricular synchrony	32
Outcomes of catheter ablation of ventricular arrhythmia originating from the left ventricular summit: A multicenter study	31
A novel 9-partition method using fluoroscopic images for guiding left bundle branch pacing	31
Durability of posterior wall isolation after catheter ablation among patients with recurrent atrial fibrillation	31
Behavior of the PR interval with increasing heart rate in patients with COVID-19	31
Structure and function of the ventricular tachycardia isthmus	30

Predictors of adverse outcome in patients with frequent premature ventricular complexes: The ABC-VT risk score	30
Differentiating hereditary arrhythmogenic right ventricular cardiomyopathy from cardiac sarcoidosis fulfilling 2010 ARVC Task Force Criteria	30
Enhanced electrocardiographic monitoring of patients with Coronavirus Disease 2019	30
Long-term complications in patients implanted with subcutaneous implantable cardioverter-defibrillators: Real-world data from the extended ELISIR experience	29
Clinical characteristics and determinants of the phenotype in TMEM43 arrhythmogenic right ventricular cardiomyopathy type 5	28
Temperature monitoring and temperature-driven irrigated radiofrequency energy titration do not prevent thermally induced esophageal lesions in pulmonary vein isolation: A randomized study controlled b	28
Axillary vein puncture guided by ultrasound vs cephalic vein dissection in pacemaker and defibrillator implant: A multicenter randomized clinical trial	28
Ostial dimensional changes after pulmonary vein isolation: Pulsed field ablation vs radiofrequency ablation	28
Temperature- and flow-controlled ablation/very-high-power short-duration ablation vs conventional power-controlled ablation: Comparison of focal and linear lesion characteristics	28
Contrast-enhanced image-guided lead deployment for left bundle branch pacing	28
Anatomic approach with bipolar ablation between the left pulmonic cusp and left ventricular outflow tract for left ventricular summit arrhythmias	28
Smartwatch-based detection of cardiac arrhythmias: Beyond the differentiation between sinus rhythm and atrial fibrillation	27
Arrhythmia recurrence is more common in females undergoing multiple catheter ablation procedures for persistent atrial fibrillation: Time to close the gender gap	27
Cardiac arrhythmias and sudden unexpected death in epilepsy: Results of long-term monitoring	26
Age at diagnosis of Brugada syndrome: Influence on clinical characteristics and risk of arrhythmia	26
Atrial fibrillation burden and heart failure: Data from 39,710 individuals with cardiac implanted electronic devices	26
Letter to the Editor—Lifesaving therapy inhibition by phones containing magnets	26
New electromechanical substrate abnormalities in high-risk patients with Brugada syndrome	26
Permanent conduction system pacing for congenitally corrected transposition of the great arteries: A Pediatric and Congenital Electrophysiology Society (PACES)/International Society for Adult Congenit	26
Appropriate and inappropriate shocks in hypertrophic cardiomyopathy patients with subcutaneous implantable cardioverter-defibrillators: An international multicenter study	26
Incidence of arrhythmias and electrocardiographic abnormalities in symptomatic pediatric patients with PCR-positive SARS-CoV-2 infection, including drug-induced changes in the corrected QT interval	26
Scar channels in cardiac magnetic resonance to predict appropriate therapies in primary prevention	26
Computer versus cardiologist: Is a machine learning algorithm able to outperform an expert in diagnosing a phospholamban p.Arg14del mutation on the electrocardiogram?	26
Repeated exposure to transient obstructive sleep apnea–related conditions causes an atrial fibrillation substrate in a chronic rat model	25
Direct comparison of a novel antitachycardia pacing algorithm against present methods using virtual patient modeling	25
Common wearable devices demonstrate variable accuracy in measuring heart rate during supraventricular tachycardia	25
Atrioventricular junction ablation in patients with conduction system pacing leads: A comparison of His-bundle vs left bundle branch area pacing leads	25
Does pulsed field ablation regress over time? A quantitative temporal analysis of pulmonary vein isolation	24
Evaluation of the reentry vulnerability index to predict ventricular tachycardia circuits using high-density contact mapping	24
Epidemiology of cardiac implantable electronic device infections in the United States: A population-based cohort study	24
Recommendations regarding cardiac stereotactic body radiotherapy for treatment refractory ventricular tachycardia	24
Physical activity and atrial fibrillation: Data from wearable fitness trackers	24
Fatal arrhythmias: Another reason why doctors remain cautious about chloroquine/hydroxychloroquine for treating COVID-19	24
Nationwide burden of sudden cardiac death: A study of 54,028 deaths in Denmark	23
Identification of patients at risk of sudden cardiac death in congenital heart disease: The PRospEctiVE study on implaNTable cardIOverter defibrillator therapy and suddeN cardiac death in Adults with	23
The role of long noncoding RNAs in atrial fibrillation	23
Loss of ventricular preexcitation during noninvasive testing does not exclude high-risk accessory pathways: A multicenter study of WPW in children	23
Pacing in vasovagal syncope: Physiology, pacemaker sensors, and recent clinical trials—Precise patient selection and measurable benefit	23
Efficacy and safety of combined endocardial/epicardial catheter ablation for ventricular tachycardia in Chagas disease: A randomized controlled study	22
Role of angiopoietin-like protein 2 in atrial fibrosis induced by human epicardial adipose tissue: Analysis using an organo-culture system	22
Cybersecurity: The need for data and patient safety with cardiac implantable electronic devices	22
Common and rare susceptibility genetic variants predisposing to Brugada syndrome in Thailand	22
Clinical profile and long-term follow-up of a cohort of patients with desmoplakin cardiomyopathy	22
Predictive value of atrial fibrillation during the postradiofrequency ablation blanking period	22
Eligibility for subcutaneous implantable cardioverter-defibrillator in congenital heart disease	22
Pacing-induced cardiomyopathy: A systematic review and meta-analysis of definition, prevalence, risk factors, and management	22
Electrical and structural remodeling contribute to atrial fibrillation in type 2 diabetic db/db mice	22
HRS/EHRA/APHRS/LAHRS/ACC/AHA worldwide practice update for telehealth and arrhythmia monitoring during and after a pandemic	21
Left ventricular summit arrhythmias with an abrupt V3 transition: Anatomy of the aortic interleaflet triangle vantage point	21
The role of timing in treatment of atrial fibrillation: An AFFIRM substudy	21
Prophylactic (hydroxy)chloroquine in COVID-19: Potential relevance for cardiac arrhythmia risk	21
Identification of important risk factors for all-cause mortality of acquired long QT syndrome patients using random survival forests and non-negative matrix factorization	21
Mechanism and magnitude of bipolar electrogram directional sensitivity: Characterizing underlying determinants of bipolar amplitude	21
Safety of leadless pacemaker implantation in the very elderly	21
Improving long QT syndrome diagnosis by a polynomial-based T-wave morphology characterization	21
Systematic quantification of histologic ventricular fibrosis in isolated mitral valve prolapse and sudden cardiac death	21
Focal source and trigger mapping in atrial fibrillation: Randomized controlled trial evaluating a novel adjunctive ablation strategy	21
Outer loop and isthmus in ventricular tachycardia circuits: Characteristics and implications	20
Initially unexplained cardiac arrest in children and adolescents: A national experience from the Canadian Pediatric Heart Rhythm Network	20
Multisite conduction block in the epicardial substrate of Brugada syndrome	20
The various manifestations of concealed nodofascicular/nodoventricular bypass tracts	20
Relationship of paced left bundle branch pacing morphology with anatomic location and physiological outcomes	20
Altered heart rate variability in angiotensin II–mediated hypertension is associated with impaired autonomic nervous system signaling and intrinsic sinoatrial node dysfunction	20
Subcutaneous implantable cardioverter-defibrillator troubleshooting in patients with a left ventricular assist device: A case series and systematic review	19
Self-reported physical activity and atrial fibrillation risk: A systematic review and meta-analysis	19
Comparison of measures of ventricular delay on cardiac resynchronization therapy response	19
Remote and wearable ECG devices with diagnostic abilities in adults: A state-of-the-science scoping review	19
Calcium signaling consequences of RyR2 mutations associated with CPVT1 introduced via CRISPR/Cas9 gene editing in human-induced pluripotent stem cell–derived cardiomyocytes: Comparison of RyR2-R420Q,	19
Long-term survival following transvenous lead extraction: Importance of indication and comorbidities	19
Effect of acute and chronic ethanol on atrial fibrillation vulnerability in rats	19
Connexin45 (GJC1) loss-of-function mutation contributes to familial atrial fibrillation and conduction disease	19
Ventricular tachycardia burden reduction after substrate ablation: Predictors of recurrence	19
Effect of continuous positive airway pressure therapy on recurrence of atrial fibrillation after pulmonary vein isolation in patients with obstructive sleep apnea: A randomized controlled trial	19
Impact of timing of transvenous lead removal on outcomes in infected cardiac implantable electronic devices	19
Pectoral nerve blocks decrease postoperative pain and opioid use after pacemaker or implantable cardioverter–defibrillator placement in children	19
Pericardial effusion requiring intervention in patients undergoing percutaneous left atrial appendage occlusion: Prevalence, predictors, and associated in-hospital adverse events from 17,700 procedure	18
Infectious consequences of hematoma from cardiac implantable electronic device procedures and the role of the antibiotic envelope: A WRAP-IT trial analysis	18
Venous anatomy of the left ventricular summit: Therapeutic implications for ethanol infusion	18
Considerations for drug interactions on QTc interval in exploratory COVID-19 treatment	18
Long-term transesophageal echocardiography follow-up after percutaneous left atrial appendage closure	18

High-density epicardial mapping in Brugada syndrome: Depolarization and repolarization abnormalities	18
2023 HRS/EHRA/APHRS/LAHRS expert consensus statement on practical management of the remote device clinic	18
Primary prevention implantable cardioverter-defibrillators in hypertrophic cardiomyopathy—Are there predictors of appropriate therapy?	18
Defining idiopathic ventricular fibrillation: A systematic review of diagnostic testing yield in apparently unexplained cardiac arrest	18
B-PO03-131 EFFECTS OF CONTACT FORCE ON LESION SIZE DURING PULSED FIELD ABLATION	18
Role of subcutaneous implantable loop recorder for the diagnosis of arrhythmias in Brugada syndrome: A United Kingdom single-center experience	18
Ten-year outcomes of transcaval cardiac puncture for catheter ablation after extracardiac Fontan surgery	18
Comparison of the effect of glucose-lowering agents on the risk of atrial fibrillation: A network meta-analysis	18
2021 PACES Expert Consensus Statement on the Indications and Management of Cardiovascular Implantable Electronic Devices in Pediatric Patients: Executive Summary	17
Blood-based 8-hydroxy-2′-deoxyguanosine level: A potential diagnostic biomarker for atrial fibrillation	17
Gain in real-world cardiac resynchronization therapy efficacy with SyncAV dynamic optimization: Heart failure hospitalizations and costs	17
Critical repolarization gradients determine the induction of reentry-based torsades de pointes arrhythmia in models of long QT syndrome	17
Procedural and short-term follow-up outcomes of Amplatzer Amulet occluder versus Watchman FLX device: A meta-analysis	17
Individualized ablation strategy to treat persistent atrial fibrillation: Core-to-boundary approach guided by charge-density mapping	17
Prevalence and outcome of early recurrence of atrial tachyarrhythmias in the Cryoballoon vs Irrigated Radiofrequency Catheter Ablation (CIRCA-DOSE) study	17
Determinants of outcome impact of vein of Marshall ethanol infusion when added to catheter ablation of persistent atrial fibrillation: A secondary analysis of the VENUS randomized clinical trial	17
Oral anticoagulants in extremely-high-risk, very elderly (>90 years) patients with atrial fibrillation	17
Modern mapping and ablation techniques to treat ventricular arrhythmias from the left ventricular summit and interventricular septum	16
Exercise and arrhythmic risk in TMEM43 p.S358L arrhythmogenic right ventricular cardiomyopathy	16
Clinical outcomes of catheter ablation of ventricular tachycardia in patients with arrhythmogenic right ventricular cardiomyopathy: Insights from the Johns Hopkins ARVC Program	16
Relationship between device-detected burden and duration of atrial fibrillation and risk of ischemic stroke	16
Pursue physiological pacing therapy: A better understanding of left bundle branch pacing and left ventricular septal myocardial pacing	16
Extracellular matrix remodeling precedes atrial fibrillation: Results of the PREDICT-AF trial	16
Reconsidering the multiple wavelet hypothesis of atrial fibrillation	16
Pharmacological norepinephrine transporter inhibition for the prevention of vasovagal syncope in young and adult subjects: A systematic review and meta-analysis	16
Absence of (sub-)acute cerebral events or lesions after electroporation ablation in the left-sided canine heart	16
Use of virtual visits for the care of the arrhythmia patient	16
Discrete sites of frequent premature ventricular complexes cluster within the infarct border zone and coincide with high frequency of delayed afterdepolarizations under adrenergic stimulation	16
Programming implantable cardioverter–defibrillator in primary prevention: Guideline concordance and outcomes	16
Effect of pacemaker implantation after transcatheter aortic valve replacement on long- and mid-term mortality	16
Effect of electrode size and spacing on electrograms: Optimized electrode configuration for near-field electrogram characterization	16
Left atrial appendage occlusion using intracardiac echocardiography	16
Mechanism of the effects of sodium channel blockade on the arrhythmogenic substrate of Brugada syndrome	16
Predictors of loss of capture in left bundle branch pacing: A multicenter experience	16
Double-balloon technique for retrograde venous ethanol ablation of ventricular arrhythmias in the absence of suitable intramural veins	16
Static magnetic field measurements of smart phones and watches and applicability to triggering magnet modes in implantable pacemakers and implantable cardioverter-defibrillators	16
Ventricular arrhythmias in athletes: Role of a comprehensive diagnostic workup	16
Safety and efficacy of leadless pacemaker for cardioinhibitory vasovagal syncope	16
Current of injury is an indicator of lead depth and performance during left bundle branch pacing lead implantation	15
Morbidity and mortality in patients precluded for transvenous pacemaker implantation: Experience with a leadless pacemaker	15
Optimizing lead placement for pacing in dyssynchronous heart failure: The patient in the lead	15
Sex differences in the origin of Purkinje ectopy-initiated idiopathic ventricular fibrillation	15
Is transesophageal echocardiography necessary in patients undergoing ablation of atrial fibrillation on an uninterrupted direct oral anticoagulant regimen? Results from a prospective multicenter regis	15
Sudden cardiac arrest with shockable rhythm in patients with heart failure	15
Tricuspid regurgitation outcomes in left bundle branch area pacing and comparison with right ventricular septal pacing	15
Left ventricular endocardial pacing is less arrhythmogenic than conventional epicardial pacing when pacing in proximity to scar	15
Long-term performance of a novel communicating antitachycardia pacing–enabled leadless pacemaker and subcutaneous implantable cardioverter-defibrillator system: A comprehensive preclinical study	15
Age-related differences and associated mid-term outcomes of subcutaneous implantable cardioverter-defibrillators: A propensity-matched analysis from a multicenter European registry	15
Combined epicardial and endocardial ablation for atrial fibrillation: Best practices and guide to hybrid convergent procedures	15
Frailty in patients undergoing percutaneous left atrial appendage closure	15
SCAI/HRS expert consensus statement on transcatheter left atrial appendage closure	15
Atrial arrhythmias and patient-reported outcomes in adults with congenital heart disease: An international study	15
Skin sympathetic nerve activity and ventricular rate control during atrial fibrillation	15
Improvement in sudden cardiac death risk prediction by the enhanced American College of Cardiology/American Heart Association strategy in Chinese patients with hypertrophic cardiomyopathy	14
Effects of pulsed field ablation on autonomic nervous system in paroxysmal atrial fibrillation: A pilot study	14
Association between nocturnal heart rate variability and incident cardiovascular disease events: The HypnoLaus population-based study	14
Predicting atrial fibrillation using a combination of genetic risk score and clinical risk factors	14
Electrophysiological characteristics and possible mechanism of bipolar pacing in left bundle branch pacing	14
Sinus node exit, crista terminalis conduction, interatrial connection, and wavefront collision: Key features of human atrial activation in sinus rhythm	14
Trends in utilization and spending on remote monitoring of pacemakers and implantable cardioverter–defibrillators among Medicare beneficiaries	14
Macroreentrant biatrial tachycardia relevant to interatrial septal incisions after mitral valve surgery: Electrophysiological characteristics and ablation strategy	14
2022 HRS expert consensus statement on evaluation and management of arrhythmic risk in neuromuscular disorders	14
Epicardial course of the musculature related to the great cardiac vein: Anatomical considerations and clinical implications for mitral isthmus block after vein of Marshall ethanol infusion	14
Segmental nonocclusive cryoballoon ablation of pulmonary veins and extrapulmonary vein structures: Best practices III	14
European Heart Rhythm Association (EHRA)/Heart Rhythm Society (HRS)/Asia Pacific Heart Rhythm Society (APHRS)/Latin American Heart Rhythm Society (LAHRS) expert consensus on risk assessment in cardiac	14
Secretome of atrial epicardial adipose tissue facilitates reentrant arrhythmias by myocardial remodeling	14
Cardiac resynchronization therapy and ventricular tachyarrhythmia burden	14
Evaluation of European Heart Rhythm Association consensus in patients with cardiovascular implantable electronic devices and Staphylococcus aureus bacteremia	14
2023 HRS expert consensus statement on the management of arrhythmias during pregnancy	14
Staphylococcus bacteremia without evidence of cardiac implantable electronic device infection	14
Cardiac deceleration capacity as an indicator for cardioneuroablation in patients with refractory vasovagal syncope	13
Long-term outcomes of ventricular tachycardia substrate ablation incorporating hidden slow conduction analysis	13
Implant, performance, and retrieval of an atrial leadless pacemaker in sheep	13
Feasibility of leadless left ventricular septal pacing with the WiSE-CRT system to target the left bundle branch area: A porcine model and multicenter patient experience	13
Outcomes of conduction system pacing for cardiac resynchronization therapy in patients with heart failure: A multicenter experience	13
Leadless left ventricular endocardial pacing for cardiac resynchronization therapy: A systematic review and meta-analysis	13
Cardiovascular exercise as a treatment of postural orthostatic tachycardia syndrome: A pragmatic treatment trial	13
Simultaneous epicardial–endocardial mapping of the sinus node in humans with structural heart disease: Impact of overdrive suppression on sinoatrial exits	13
Intentional nontherapy in long QT syndrome	13
Sinus Node Sparing Hybrid Thoracoscopic Ablation Outcomes in Patients with Inappropriate Sinus Tachycardia (SUSRUTA-IST) Registry	13
Purkinje system hyperexcitability and ventricular arrhythmia risk in type 3 long QT syndrome	13
Cardiac crises: Cardiac arrhythmias and cardiomyopathy during TANGO2 deficiency related metabolic crises	13
Ambulatory atrioventricular synchronous pacing over time using a leadless ventricular pacemaker: Primary results from the AccelAV study	13
Impact of myocardial fiber orientation on lesions created by a novel heated saline-enhanced radiofrequency needle-tip catheter: An MRI lesion validation study	12
Subcutaneous implantable cardioverter-defibrillator and defibrillation testing: A propensity-matched pilot study	12
Evaluation of mexiletine effect on conduction delay and bradyarrhythmic complications in patients with myotonic dystrophy type 1 over long-term follow-up	12
Anticoagulation for stroke prevention in patients with hypertrophic cardiomyopathy and atrial fibrillation: A review	12
Implantation of cardiac electronic devices in active COVID-19 patients: Results from an international survey	12
R-on-T and the initiation of reentry revisited: Integrating old and new concepts	12
Catheter-free ablation of infarct scar through proton beam therapy: Tissue effects in a porcine model	12
Preclinical safety and electrical performance of novel atrial leadless pacemaker with dual-helix fixation	12
Factors associated with remote monitoring adherence for cardiovascular implantable electronic devices	12
Distance between the lead-implanted site and tricuspid valve annulus in patients with left bundle branch pacing: Effects on postoperative tricuspid regurgitation deterioration	12
Long-term prognosis of women with Brugada syndrome and electrophysiological study	12
Biventricular endocardial pacing and left bundle branch area pacing for cardiac resynchronization: Mechanistic insights from electrocardiographic imaging, acute hemodynamic response, and magnetic reso	12